From e34e7da50fc0ff5ed41e8bdaf2b1d41c9e9cf534 Mon Sep 17 00:00:00 2001 From: Bonface Date: Thu, 15 Feb 2024 06:09:54 -0600 Subject: Update dataset RTF Files. --- .../datasets/Eye_M2_0908_R_MT/acknowledgment.rtf | 3 - general/datasets/Eye_M2_0908_R_MT/cases.rtf | 57 - .../Eye_M2_0908_R_MT/experiment-design.rtf | 1 - general/datasets/Eye_M2_0908_R_MT/notes.rtf | 1 - general/datasets/Eye_M2_0908_R_MT/platform.rtf | 11 - general/datasets/Eye_M2_0908_R_MT/processing.rtf | 3381 -------------------- general/datasets/Eye_M2_0908_R_MT/summary.rtf | 12 - general/datasets/Eye_M2_0908_R_MT/tissue.rtf | 2058 ------------ 8 files changed, 5524 deletions(-) delete mode 100644 general/datasets/Eye_M2_0908_R_MT/acknowledgment.rtf delete mode 100644 general/datasets/Eye_M2_0908_R_MT/cases.rtf delete mode 100644 general/datasets/Eye_M2_0908_R_MT/experiment-design.rtf delete mode 100644 general/datasets/Eye_M2_0908_R_MT/notes.rtf delete mode 100644 general/datasets/Eye_M2_0908_R_MT/platform.rtf delete mode 100644 general/datasets/Eye_M2_0908_R_MT/processing.rtf delete mode 100644 general/datasets/Eye_M2_0908_R_MT/summary.rtf delete mode 100644 general/datasets/Eye_M2_0908_R_MT/tissue.rtf (limited to 'general/datasets/Eye_M2_0908_R_MT') diff --git a/general/datasets/Eye_M2_0908_R_MT/acknowledgment.rtf b/general/datasets/Eye_M2_0908_R_MT/acknowledgment.rtf deleted file mode 100644 index 5098d32..0000000 --- a/general/datasets/Eye_M2_0908_R_MT/acknowledgment.rtf +++ /dev/null @@ -1,3 +0,0 @@ -

Support for acquisition of microarray data sets was generously provided by Dr. Barrrett Haik, Chair of the Department of Ophthalmology, and director of the Hamilton Eye Institute. Support for the continued development of GeneNetwork was provided by a NIDA/NIMH/NIAAA Human Brain Project grant and from funds from NEI grant to Dr. Eldon Geisert (R01EY017841), an NEI Vision Core grant (EY14080) and an Unrestricted Grant from Research To Prevent Blindness.

- -

We thank Dr. Ted Choi, Chief Scientific Director of Predictive Biology, Inc. (past director of molecular genetics at Deltagen Inc.) for providing us with eye samples from several interesting DeltaGen knockouts.

diff --git a/general/datasets/Eye_M2_0908_R_MT/cases.rtf b/general/datasets/Eye_M2_0908_R_MT/cases.rtf deleted file mode 100644 index 552d4a5..0000000 --- a/general/datasets/Eye_M2_0908_R_MT/cases.rtf +++ /dev/null @@ -1,57 +0,0 @@ -

This is the complete and final HEIMED data set. HEIMED consists of expression data for 103 genetically defined lines of mice with standard errors of the mean. Almost all animals are young adults between 50 and 80 days of age (Table 1, maximum age is 123 days). We measured expression in conventional inbred strains, BXD recombinant inbred (RI) strains, reciprocal F1s between C57BL/6J and DBA/2J, and several mutant and knockout lines. We have combined all common strains, F1 hybrids, and mutants into a group called the Mouse Diversity Panel (MDP). Four lines, namely, C57BL/6J (B6), DBA/2J (D2), and the pair of B6D2F1 and D2B6F1 hybrids are common to both the MDP and the BXD set. This is a breakdown of cases that are part of HEIMED:

- -
    -
  1. 68 BXD strains. The first 32 of these strains are from the Taylor series of BXD strains generated at the Jackson Laboratory by Benjamin A. Taylor. BXD1 through BXD32 were started in the late 1970s, whereas BXD33 through 42 were started in the 1990s. Only one of these strains, BXD24 (know also known as BXD24b), has retinal degeneration (a spontaneous mutation). The other 36 BXD strains (BXD43 and higher) were bred by Lu Lu, Jeremy Peirce, Lee M. Silver, and Robert W. Williams starting in 1997 using B6D2 generation 10 advanced intercross progeny. This modified breeding protocol doubles the number of recombinations per BXD strain and improves mapping resolution (Peirce et al. 2004). All of the Taylor series of BXD strains and many of the new BXD strains are available from the Jackson Laboratory. All of the new BXD strains (BXD43 and higher) are also available directly from Lu Lu and colleagues at the University of Tennessee Health Science Center in Memphis, TN, USA.
    2. -
  2. 35 MDP lines, including 26 inbred strains representing closely related substrains (e.g, BALB/cJ and BALB/cByJ), many of the most widely used common Mus musculus domesticus inbred strains (e.g., C57BL/6J and 129S1/SvImJ), inbred but wild-derived representatives of common subspecies (Mus musculus domesticus, e.g, WSB/EiJ; M. musculus musculus, e.g., CZECHII/EiJ; M. musculus molossinus, e.g., MOLF/EiJ; M. musculus castaneus, e.g., CAST/EiJ); and even one different species of mouse (Mus spicilegus, PANCEVO/EiJ). The MDP also includes the reciprocal F1 hybrids (B6D2F1 and D2B6F1) and the following 6 KO lines and the Nyx-nob mutant:
    3. -
  3. 6 knockouts (KO), including a KO of Rpe65, and 5 DeltaGen Inc. knockout lines provided by Dr. Ted Choi. These KO lines have had a bacterial lacZ construct inserted into the gene. The endogenous promoter drives expression of beta-galactosidase. RT-PCR analysis detects a gene transcript in most tissues. The following KOs from DeltaGen were studied: Gabra1, Gabbr1, Gnb1, Gpr19, and Clcn3. We also included one spontaneous mutant of the nyctalopin (Nyx no b wave "nob") gene (Pardue et al., 1998) that is on a BALB/cByJ background.
    4. -
- -

Rod photoreceptor degeneration in inbred mice: Six strains of mice included in HEIMED suffer from severe loss of photoreceptors (mainly rods) and have the equivalent of night blindness in human patients. The death of photoreceptors in these strains occurs by one to two months of age and is often caused by the retinal degeneration 1 (rd1) mutant allele in the rod cyclic-GMP phosphodiesterase 6 beta subunit gene (Pde6b). The following strains are known to have photoreceptor degeneration: C3H/HeJ, FVB/NJ, MOLF/EiJ, SJL/J and BXD24/TyJ. BXD24/TyJ is now known as BXD24b/TyJ and has nearly complete retinal degeneration. BXD24a/TyJ, a 1988 F80 inbred stock that has been rederived from cryogenic storage, does not have retinal degeneration (stock number 005243) and is an ideal coisogenic control, but is not included in the HEIMED data set.

- -

As expected (Dickerson LW et al., 2002) and as judged from the absence of rhodopsin expression, one of the DeltaGen KO lines (chloride ion channel 3, Clcn3) also has retinal degeneration: B6129P2F2N1-Clcn3. Degeneration in this strain is likely to include all rods and all cones. The cone defect is obvious from the decrease in expression of Gnat2, a gene associated with cones and achromatopsia in mice and humans.

- -

Lines of mice were selected using the following criteria:

- - - -

We have included all eight parents of the Collaborative Cross (129S1/SvImJ, A/J, C57BL/6J, CAST/EiJ, NOD/LtJ, NZO/HlLtJ, PWK/PhJ, and WSB/EiJ) in the MDP. Fourteen MDP strains have been partially sequenced by Perlegen for the NIEHS, including including 129S1/SvImJ, A/J, AKR/J, BALB/cByJ, C3H/HeJ, CAST/EiJ, DBA/2J, FVB/NJ, KK/HlJ, MOLF/EiJ, NOD/LtJ, NZW/LacJ, PWD/PhJ, and WSB/EiJ (see the GeneNetwork SNP Browser for data, details, and see Perlegen's excellent data resources and browser).

- -
    -
  1. 129S1/SvImJ : Collaborative Cross strain sequenced by NIEHS; background for many knockouts (R1 ES cell line); Phenome Project A list. This strain (JAX No 002448, aka 129S1/Sv-++Kitl/+) carries hypopigmentation mutations (white bellied chinchilla) of the tyrosinase gene on Chr 7 and a mutant allele of the steel (Kitl) gene. It is also a cone photoreceptor function loss 3 mutant (Cpfl3 allele) of the Gnat2 gene that is a model for achromatopsia (JAX Stock Number: 002448)
    2. -
  2. A/J: Collaborative Cross strain sequenced by Perlegen/NIEHS; parent of the AXB/BXA panel. A tyrosinase (Tyr c allele) albino mutant. This strain is particularly sensitive to light-induced photoreceptor loss (Danciger et al., 2007). (JAX Stock Number: 000646)
    3. -
  3. BALB/cByJ: Sequenced by NIEHS; maternal parent of the CXB panel; Phenome Project old group A list. A tyrosinase (Tyr c allele) albino mutant and also a tyrosinase related protein 1 (Tyrp1 b) brown allele mutant. Small brain, not aggressive (JAX Stock Number: 001026)
    4. -
  4. BALB/cJ: Phenome Project A list. A tyrosinase (Tyr c allele) albino mutant and also a tyrosinase related protein 1 (Tyrp1 b) brown allele mutant. Large brain and aggressive (JAX Stock Number: 000651)
    5. -
  5. BXSB/MpJ: A white-bellied agouti strains with interesting autoimmune disease restricted to males that is associated with a mutation in the Yaa gene that causes glomerulonephritis, a dramatic increase in number of peripheral monocytes, and pre-B-cell deficiency (JAX Stock Number: 000740)
    6. -
  6. C3H/HeJ: The Heston (He) substrain with a wildtype agouti (A allele) coat color. Sequenced by Perlegen/NIEHS; paternal parent of the BXH panel; Phenome Project old group A list. Important to note for this eye expression dataset, C3H/HeJ is a Pdeb6 rd1 mutant with near total photoreceptor loss at as early as postnatal day 30. Also a Tlr4 mutant that is endotoxin resistant. (JAX Stock Number: 000659)
    7. -
  7. C57BL/6J: Sequenced by NIH/NHGRI; parental strain of AXB/BXA, BXD, and BXH; Phenome Project A list. Single most widely used inbred strain of mouse. (JAX Stock Number: 000664)
    8. -
  8. C57BLKS/J: Black Kaliss strain (non-agouti a allele) derived from C57BL/6J, but genetically contaminated at some point mainly with DBA/2J and then reinbred. Now at the Jackson Laboratory. (JAX Stock Number: 000662)
    9. -
  9. CAST/EiJ: A wild-derived inbred Mus musculus castaneus strain. Samples of this subspecies were captured in Southeast Asia. One of three wild-derived strains in the Collaborative Cross sequenced by NIEHS; Phenome Project A list. CAST/Ei and CAST/EiJ are the same strain. The addition of the "J" is trivial and was added when stock were transferred from Dr. Eicher's lab to the Jackson Laboratory production facility in about 2004. (JAX Stock Number: 000928)
    10. -
  10. CBA/CaJ: Agouti strain from the Jackson Laboratory. Wildtype pigment genes. (JAX Stock Number: 000654)
    11. -
  11. CZECHII/EiJ: Czech 2 is a wild-derived inbred strain M. musculus musculus strain. Samples of this subspecies were caught in the Czech Republic and inbred at the Jackson Laboratory by Eva Eicher. White-bellied agouti. (JAX Stock Number: 001144).
    12. -
  12. DBA/2J: The dilute, brown, agouti (dba) strain is the oldest inbred strain of mouse. Inbreeding was started in 1909 by Little. A tyrosinase related protein 1 (Tyrp1 b) brown allele mutant. A myosin 5a (Myo5a d) dilute allele mutant. Sequenced by Perlegen/NIEHS and Celera; paternal parent of the BXD panel; Phenome Project old A group list. (JAX Stock Number: 000671)
    13. -
  13. FVB/NJ: Friend's leukemia virus B (FVB) strain. Sequenced by Perlegen/NIEHS and Celera. Tyr c locus albino and a Pdeb6 rd1 mutant derived from Swiss mice at NIH. This has been the most common strain used to make transgenic mice due to large and easily injected oocytes; Phenome Project A list (JAX Stock Number: 001800).
    14. -
  14. KK/HlJ: K Kondo's (KK) Kasukabe strain is a homozygous age-related hearing loss (ahl) allele mutant of the Cdh23 gene. A Tyr c locus albino strain. Males have a form of type 2 diabetes. Sequenced by Perlegen/NIEHS. (JAX Stock Number: 002106)
    15. -
  15. LG/J: Large (LG) strain. Paternal parent of the Large-by-Small set of RI strains made by James Cheverud and colleagues (the LGXSM panel, not to be confused with the LongXShort or LXS panel). A Tyr c locus albino strain. (JAX Stock Number: 000675)
    16. -
  16. LP/J: White-bellied agouit strain with a piebald mutation in the endothelin receptor type B Ednrb gene from at the Jackson Laboratory. Some reduction in melanocytes in choroid of eye due to neural creast migration abnormalities. (JAX Stock Number: 000676)
    17. -
  17. MOLF/EiJ: A wild-derived inbred strain derived from M. musculus molossinus samples camputered in Fukuoka, Japan. This strain has the retinal degeneration rd1 allele in Pde6b. There appears to have been some genetic contamination of this strain with conventional inbred strains in the past several decades (F. Pardo, personal communication to RWW, August 2006). However, the strain is currently fully inbred. (JAX Stock Number: 000550)
    18. -
  18. NOD/LtJ: Non-obese diabetic strain, originally from M. Hattori in Kyoto, Japan. This is the Edward Leiter (Lt) substrain from the Jackson Laboratory. Collaborative Cross strain sequenced by NIEHS; Phenome Project B list. Homozygous age-related hearing loss (ahl) allele mutant of the Cdh23 gene. A Tyr c locus albino strain. (JAX Stock Number: 001976)
    19. -
  19. NZO/HlLtJ: New Zealand Obese strain. This is a severely obese and hypertensive strain. Males often develop a type 2 diabetes. Collaborative Cross strain. Agouti coat color. (JAX Stock Number: 002105)
    20. -
  20. NZB/BlNJ: New Zealand Black inbred strain from Bielschowsky (BL, substrain is "B lowercase L N", not "BiN") now maintained at the Jackson Laboratory. (JAX Stock Number: 000648)
    21. -
  21. NZW/LacJ: New Zealand White strain from the Laboratory Animal Center (Carshalton, UK), now maintained at the Jackson Laboratory. Carries the Tyr c locus albino mutation, the pink-eye dilution mutation in the Oca2 or p locus, and the brown allele at Tyrp1. (JAX Stock Number: 001058)
    22. -
  22. PANCEVO/EiJ: PANCEVO/EiJ is a wild-derived inbred strain from the Mus spicilegus samples caught in the Pancevo, Serbia. This species of mouse is also known as the Steppe mouse (taxon identifier 10103). M. spicilegus is a colonial mound-building species. No known ocular or retina mutations, but the expression level of Gnat2 is low in this strain, either due to a 3' UTR length variant or possible achromatosia (cone degeneration) (JAX Stock Number: 001384)
    23. -
  23. PWD/PhJ: A wild-derived Mus musculus musculus agouti strain inbred from samples caught near Prague, Czech Republic. Sequenced by Perlegen/NIEHS; parental strain for a consomic set by Forjet and colleagues. (JAX Stock Number: 004660)
    24. -
  24. PWK/PhJ: A wild-derived Mus musculus musculus inbred strain from samples caught near Lhotka, Czech Republic. Collaborative Cross strain; Phenome Project D list. (JAX Stock Number: 003715)
    25. -
  25. SJL/J: Swiss Webster inbred strain from Jim Lambert's lab at the Jackson Laboratory. This strain has the retinal degeneration rd1 allele in Pde6b. It also carries both the Tyr c albino mutation and the pink-eye dilution mutation in the Oca2 or p locus. Highly aggressive males. (JAX Stock Number: 000686)
    26. -
  26. WSB/EiJ: Watkin Star line B (or "wild son-of-a-bitch") is a wild-derived Mus musculus domesticus inbred strain from samples caught in Maryland, USA. A Collaborative Cross strain sequenced by NIEHS; Phenome Project C list (JAX Stock Number: 001145)
    27. -
  27. B6D2F1 and D2B6F1 (also listed as BDF1 and DBF1 in some graphs and tables): F1 hybrids generated by crossing C57BL/6J with DBA/2J. These black reciprocal F1 can be used to detect dominance effects. Comparison of the two reciprocal F1s can be used to detect parental origin (imprinting) effects. The D2B6F1 animals are currently available from the Jackson Laboratory as a special order.) (JAX Stock Number for B6D2F1 hybrids obtained from the Jackson Laboratory, aka B6D2F1/J 100006)
    28. -
- -

Most of the common inbred strains harbor mutations in genes the control pigmentation (Silvers, 2008 and material above in this INFO file). These gene include the albino and chinchilla alleles of the tyrosinase gene (Tyr, or human OCA1), the brown allele of the tyrosinase related protein 1 (Tyrp1), the pink-eye dilution allele of Oca2 (probe set 1418211), the non-agouti (black) and white-bellied alleles of the agouti signaling protein Asip, the steel allele of Kitlg, the dilute allele of Myo5a (probe set 1419754), and the piebald allele of Ednrb. In some of these cases, effects of the mutation are easily detected at the transcript level (Tyrp1, Oca2, and Myo5a), but in the other cases (Tyr, Asip, Ednrb, and Kitlg), mutations do not leave a strong imprint on expression.

diff --git a/general/datasets/Eye_M2_0908_R_MT/experiment-design.rtf b/general/datasets/Eye_M2_0908_R_MT/experiment-design.rtf deleted file mode 100644 index 1ebe0ad..0000000 --- a/general/datasets/Eye_M2_0908_R_MT/experiment-design.rtf +++ /dev/null @@ -1 +0,0 @@ -

Expression profiling by array

diff --git a/general/datasets/Eye_M2_0908_R_MT/notes.rtf b/general/datasets/Eye_M2_0908_R_MT/notes.rtf deleted file mode 100644 index 7a26eb5..0000000 --- a/general/datasets/Eye_M2_0908_R_MT/notes.rtf +++ /dev/null @@ -1 +0,0 @@ -

This data set is available as a bulk download in several formats. The data are available as either strain means or the individual arrays. Due to the involved normalization procedures required to correct for batch effects we strongly recommend not using the raw CEL files without special statistical procedures.

diff --git a/general/datasets/Eye_M2_0908_R_MT/platform.rtf b/general/datasets/Eye_M2_0908_R_MT/platform.rtf deleted file mode 100644 index 9024a99..0000000 --- a/general/datasets/Eye_M2_0908_R_MT/platform.rtf +++ /dev/null @@ -1,11 +0,0 @@ -

Affymetrix Mouse Genome 430 2.0 arrays: The 430 2.0 array consists of 992936 25-nucleotide probes that estimate the expression of approximately 39,000 transcripts (many probes overlap and target the same transcript). The array sequences were selected late in 2002 using Unigene Build 107. The array nominally contains the same probe sequences as the old M430A and 430B array pair. However, we have found that roughy 75000 probes differ between those on A and B arrays and those on the new 430 2.0.

- -

As part of the development of HEIMED, we have manually annotated individual probe sets by sequence alignment to the mouse genome and transcriptome. Approximately 13,000 probe sets that have comparatively high expression in eye and CNS were curated by one of the authors (RWW) and now have specific information on the part of the transcript targeted by each probe set. The other 33,000 transcripts have corresponding data that was generated by Xusheng Wang using computational methods (BLAT analysis combined with annotated genome sequence).

- -

One example may help explain how to exploit this annotation. The four probe sets for rhodopsin include information on the target location. Only the first probe set targets the last two coding exons. The other three probe sets target different parts of the 3’ UTR (mid, distal, and far distal regions). The probe sets can be reordered by from high to low expression using the Sort By function in Search Results pages. In the case of rhodopsin, the probe set that targets that last two coding exons and proximal parts of the 3’ UTR also has the highest expression . Finally, the HEIMED gene descriptions have been customized to help vision researchers. In the case of rhodopsin, the description appended after the gene name reads “rod photoreceptor pigment, retinitis pigmentosa-associated”. For less well known genes this kind of annotation can be extremely useful. For example, the more verbose annotation for Cerkl reads “neuronal survival and apoptosis-related, retinal ganglion cell expressed, retinitis pigmentosa 26); alternative 3' UTR of short form message, intron 2”.

- -

 

- -

- -

Legend: Distribution of expression values for all probe sets in HEIMED.

diff --git a/general/datasets/Eye_M2_0908_R_MT/processing.rtf b/general/datasets/Eye_M2_0908_R_MT/processing.rtf deleted file mode 100644 index 4349e60..0000000 --- a/general/datasets/Eye_M2_0908_R_MT/processing.rtf +++ /dev/null @@ -1,3381 +0,0 @@ -

Range of Gene Expression in the Eye. Expression of transcripts in the HEIMED and most other GN data sets is measured on a log2 scale. Each unit corresponding approximately to a 2-fold difference in hybridization signal intensity. To simplify comparisons among different data sets and cases, log2 RMA values of each array have been adjusted to an average expression of 8 units and a standard deviation of 2 units (variance stabilized). Values of all 45,101 probe sets in this data set range from a low of 4.8 (Tcf15, probe set 1420281_at) to a high of 15.5 (crystallin gamma C, Crygc, probe set 1422674_s_at). This corresponds to 10.7 units or a 1 to 1700 dynamic range of expression (2^10.73).

- -

We used pooled RNA samples of whole eyes, usually two independent pools--one male, one female pool--for most lines of mice. This data set was processed using the RMA protocol. A total of 2223 probes sets are associated with LRS values greater than 46 (LOD >10).

- -

We calibrated this log intensity scale using Affymetrix spike-in control probe sets. These 18 control probe sets target exogenous bacterial mRNAs that are added to each sample (a graded dose spike cocktail) during preparation at concentrations of 1.5, 5, 25, and 100 pM. (To find these probe sets, search GN’s ALL search field using the string “AFFX pM”.) A value of 6 or less is equivalent to an mRNA concentration of under 0.4 pM, a value of 8 is equivalent to ~1.5 pM, 9.5 is equivalent to ~5 pM, 11.5 is equivalent to ~25 pM, 13.5 is equivalent to ~100 pM, and a value of 15.5 is equivalent to an mRNA concentration of 400 pM or greater.

- -

This range can be converted to the mRNA molecules per cell in the eye assuming that a value of 8 is equivalent to about 1 mRNA copy per cell (Kanno et al. 2006, see http://www.biomedcentral.com/1471-2164/7/64). Since the expression of rhodopsin mRNA is normally 15 units, we predict that there are 27 or ~128 Rho mRNAs per cell in the whole eye and ~256 in rods themselves (assuming that rods make up about half of all cells in the eye). For this purpose it may be useful to know that a normal mouse eye contains between 6 and 8 million rod photoreceptors (Guo, Lu, and Williams; GN BXD Phenotype ID 11024).

- -

Note that some probe sets with very low expression still provide reliable data. For example, probe set 1440397_at (Cacna2d1) has expression of only 5.5 units (a value that would be declared as "absent" using conventional Affymetrix procedures), but the values for this calcium channel transcript are associated with a very strong cis QTL with an LRS of 79 (LOD = 17). This strong linkage is definitely not due to chance since the probability of the expression data mapping precisely to the location of the parent gene itself is about 10e-16. This indicates a high signal to noise ratio and the detection of significant strain variation of the correct transcript.

- -

The standard error of the mean for the HEIMED data set is computed for 2 to 6 biological replicates. The standard error of such small samples tends to systematically underestimate the population standard error. With n = 2 the underestimate is about 25%, whereas for n = 6 the underestimate is 5%. Gurland and Tripathi (1971) provide a correction and equation for this effect (see Sokal and Rohlf, Biometry, 2nd ed., 1981, p 53 for an equation of the correction factor for small samples of n < 20.) Probe (cell) level data from the CEL file: These CEL values produced by GCOS are 75% quantiles from a set of 91 pixel values per cell. The CEL files were processed using the RMA protocol. We processed the first three batches together. The last batch was processed separately and merged as described below.

- - - -

After RMA processing using Biobase affy10 build running under R version 2.7.1, all array data sets were rank-order normalized. This second round of quantile normalization removes much residual non-linearity across arrays and forces every array to have the same distribution of values as the mean of all arrays. Comparative array data quality was then evaluated in DataDesk. Outlier arrays were flagged by visual inspection in DataDesk, usually by means of an analysis of scatter plots and more quantitatively by generating a correlation matrix of all arrays. Those arrays with mean correlation <0.96 versus all other arrays indicates trouble or a biological outlier). In some cases, outliers were expected, such as samples from strains with retinal degeneration (FVB/NJ, NOD/LtJ, MOLF/EiJ, C3H/HeJ and BXD24), samples from wild subspecies such as WSB/EiJ, CAST/EiJ, PWD/PhJ, and PWK/PhJ, and knockouts. However, when arrays were anomolous both within strain and across strains, they were often simply discarded. The assumption is that anomolous data are much more likely due to experimental and technical errors than to informative biological variation. Approximately 10% of arrays were discarded.

- -

After this process, the acceptable set of arrays was renormalized using all step as above, starting with the original RMA procedure, etc.

- -

We reviewed the data set using a new method developed by RW Williams, Jeremy Peirce, and Hongqiang Li. For the full set of arrays that passed standard QC protocols described above, we computed the strain means for the BXD strains, B6, D2, and F1s. Using this set of strain means we then computed LRS scores for all 45101 probe sets and counted the number of transcripts that generated QTLs with LRS values greater than 50. This value (e.g., 1800) represented the QTL harvest for the full data set. We then dropped a single array from the data set, recomputed strain means, and recomputed the number of transcripts with LRS scores great than 50. This value is expected to typically reduce the number of QTLs that reach the criterion level (e.g., 1750 QTLs > 50). This process was repeated for every array to obtain an array-specific difference value--the effect of removing that array on the total QTL count. For example, the loss of a single array might cause a decrease in 50 QTLs. Values ranged from approximately -90 (good arrays) to +40 (bad arrays). This procedure is similar in some ways to a jackknife protocol, although we are not using this procedure to esimate an error term, but rather as a method to polish a data set.

- -

During this process we discovered that nearly 20 arrays in the batch 2 had been mislabeled at some point in processing. We computed the correct strain membership of each array using a large number of Mendelian probe sets (more than 50) and comparing their match to standard SNP and microsatellite markers and the original array data set of November 2005. This allowed us to rescue a large number of arrays that were of high quality.

- -

A third batch of approximately 40 arrays were processed by Yan Jiao and Weikuan Gu in August 2006. These complete data set assembled by Hongqiang Li. This process again included a correction for a batch effect.

- -

For the June 2006 data set Hongqiang Li used a new batch correction method that stabilizes the range of expression in each batch. For each of the three large batches, we extracted the minumum and maximum raw probe expression (CEL file level) value. We then adjusted raw probe values in each batch to have the same range as the first and largest batch (batch 1) using a simple linear interpolation. These procedures generated new correct CEL files which were then used with RMA to generate final probe set estimates.

- -

For the final fourth batch of arrays (Sept 2008) Arthur Centeno and Rob Williams corrected for a systematic difference in probe set expression values between original arrays run in 2005 and 2006 and the new arrays added in 2008 (n = 45 acceptable arrays). This difference is due to unknown technical batch effects that are probably associated with labeling, hybridization, and scanning. We performed a simple correction to normalize values of the new set of arrays to those of the old set (batches 1 through 3). No changes were made to any values of the previous three batches. We corrected only the probe set level (RMA) values and not the CEL files. For this final batch, we corrected for the difference (offset) in probe set expression between the first three batches arrays run in 2005 and 2006 (a total of 174 acceptable arrays) and the new batch (n = 47 acceptable arrays). This difference is due to unknown technical effects that are probably related to various steps in labeling, hybridization, and scanning. The correction was applied as follows: (1) RWW selected 51 high quality arrays with similar expression characteristics (r = 0.97 or better between pairs of arrays) in the old data set (from batches 1, 2, and 3) and 34 high quality arrays in the final batch. RWW used scatterplots of full RMA transcriptome data sets to review many pairs of arrays within these new and old array batches. Strains with retinal degeneration or unusual eye gene expression characteristics were excluded from these selected subsets. The average expression values for each probe set were then computed for both the old and new array subsets. The offset value (old minus new) was added to each probe set across all 47 new arrays. This processes forces the average probe set in the new arrays to be very close to that of the previous arrays.

- -

Table 2: Sample tube ID, strain, original CEL filename, and Affymetrix quality control values. Columns labeled Scale factor, Background Average, Present, Absent, Marginal and 3'/5' ratios for actin and Gapdh were collated from the Affymetrix Report (RPT) files.

- -

 

- - - - - - - -
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
IndexTubeIDStrainOriginal CELScale factorBackground AveragePresentAbsentMarginalAFFX-b-ActinMur (3'/5')AFFX-GapdhMur (3'/5')Batch IdUsed for batch control
1R2595E.1129S1/SvImJR2595E.1.CEL1.7911561.00%37.50%1.50%1.460.771Y
2R2533E.1129S1/SvImJR2533E.1.CEL2.119457.90%40.50%1.60%1.370.781Y
3R0754E.1A/JR0754E.1.CEL2.728659.80%38.70%1.50%1.360.761Y
4R4521EB6129P2F2N1-Clcn3R4521E.CEL4.8338.763.30%35.30%1.40%1.250.774 
5R4522EB6129P2F2N1-Clcn3R4522E.CEL5.7637.3662.90%35.70%1.40%1.370.834 
6R4523EB6129P2F2N1-Clcn3R4523E.CEL4.8840.4263.90%34.70%1.40%1.270.774 
7R4526EB6129P2F2N1-Gabbr1R4526E.CEL3.8444.1865.00%33.70%1.30%1.340.784Y
8R4509EB6129P2F2N1-Gabbr1R4509E.CEL7.4534.7658.90%39.70%1.40%1.450.834 
9R4510EB6129P2F2N1-Gabbr1R4510E.CEL8.4437.4457.40%41.10%1.50%1.350.834 
10R4511EB6129P2F2N1-Gabbr1R4511E.CEL5.9142.0261.40%37.20%1.40%1.410.834 
11R4524EB6129P2F2N1-Gabbr1R4524E.CEL5.4942.3462.40%36.20%1.40%1.290.784Y
12R4525EB6129P2F2N1-Gabbr1R4525E.CEL4.6941.363.10%35.50%1.40%1.270.84Y
13R4515EB6129P2F2N1-Gabra1R4515E.CEL5.7541.7662.80%35.80%1.40%1.410.814Y
14R4516EB6129P2F2N1-Gabra1R4516E.CEL7.0740.7360.20%38.40%1.40%1.320.874Y
15R4517EB6129P2F2N1-Gabra1R4517E.CEL5.4538.0962.70%35.80%1.40%1.340.824Y
16R4512EB6129P2F2N1-Gnb5R4512E.CEL6.5638.0259.90%38.70%1.50%1.330.834 
17R4513EB6129P2F2N1-Gnb5R4513E.CEL4.1541.663.40%35.10%1.50%1.340.824 
18R4514EB6129P2F2N1-Gnb5R4514E.CEL5.8639.261.20%37.30%1.50%1.340.814 
19R4518EB6129P2F2N1-Gpr19R4518E.CEL5.5838.962.60%36.00%1.30%1.390.794Y
20R4519EB6129P2F2N1-Gpr19R4519E.CEL5.9541.9161.30%37.30%1.40%1.350.844Y
21R2601E.1B6D2F1R2601E.1.CEL2.559258.90%39.60%1.50%1.440.781Y
22R2602E.1B6D2F1R2602E.1.CEL2.68459.70%38.80%1.50%1.370.781Y
23R1676E.1BALB/cByJR1676E.1.CEL2.699858.90%39.60%1.50%1.460.741 
24R1672E.1BALB/cByJR1672E.1.CEL2.2211159.90%38.60%1.50%1.260.81Y
25R4530EBALB/cJR4530E.CEL6.3737.5360.80%37.80%1.40%1.30.844Y
26R4529EBALB/cJR4529E.CEL5.7141.3360.50%38.00%1.50%1.480.84Y
27R2704E.2BXD1R2704E.2.CEL2.066139.6156.60%41.90%1.50%1.310.812 
28R2707E.3BXD1R2707E.3.CEL18056.40%42.10%1.50%1.430.793 
29R1231E.2BXD2R1231E.2.CEL2.197138.7357.30%41.30%1.40%1.410.772 
30R2598E.1BXD2R2598E.1.CEL1.9910660.90%37.60%1.50%1.270.781Y
31R2591E.1BXD5R2591E.1.CEL1.713658.50%40.00%1.50%1.330.781Y
32R2714E.2BXD5R2714E.2.CEL1.404144.3560.60%37.90%1.50%1.430.792 
33R2570E.1BXD6R2570E.1.CEL1.998758.50%40.00%1.50%1.460.761Y
34R2694E.2BXD6R2694E.2.CEL1.98397.2361.60%37.10%1.30%1.390.822 
35R2538E.1BXD8R2538E.1.CEL1.9110261.20%37.30%1.50%1.520.791Y
36R2709E.2BXD8R2709E.2.CEL1.9999.7960.90%37.60%1.50%1.420.762 
37R2708E.2BXD9R2708E.2.CEL1.966126.4657.70%40.70%1.50%1.40.842 
38R2569E.1BXD9R2569E.1.CEL1.758755.10%43.40%1.50%2.823.141 
39R2581E.1BXD11R2581E.1.CEL1.948962.10%36.40%1.60%1.550.811Y
40R2612E.2BXD11R2612E.2.CEL1.83142.0358.20%40.50%1.40%1.780.812 
41R2742E.2BXD12R2742E.2.CEL2.127134.1457.00%41.60%1.40%1.640.782 
42R2543E.1BXD12R2543E.1.CEL1.6111858.60%39.90%1.60%1.430.771Y
43R2586E.1BXD13R2586E.1.CEL2.017456.40%42.00%1.60%2.853.811 
44R877E.2BXD13R877E.2.CEL1.558125.6361.20%37.50%1.20%1.420.812 
45R2557E.1BXD14R2557E.1.CEL1.839962.50%36.10%1.40%1.310.781Y
46R1128E.2BXD14R1128E.2.CEL1.9111559.90%38.80%1.40%1.20.821Y
47R2701E.3BXD15R2701E.3.CEL18860.60%37.90%1.40%1.50.773 
48R2716E.2BXD15R2716E.2.CEL2.015150.8356.40%42.10%1.60%1.420.812 
49R2711E.2BXD16R2711E.2.CEL1.953118.5359.00%39.60%1.50%1.450.82 
50R2567E.1BXD16R2567E.1.CEL2.248256.70%41.60%1.70%1.370.751 
51R2720E.2BXD18R2720E.2.CEL2.3299.9359.50%39.00%1.50%1.330.772 
52R2559E.1BXD18R2559E.1.CEL1.6510460.80%37.70%1.50%1.270.781Y
53R2560E.1BXD19R2560E.1.CEL1.799860.90%37.50%1.60%1.350.81Y
54R2713E.2BXD19R2713E.2.CEL1.67120.8260.20%38.30%1.50%1.450.82 
55R2584E.1BXD20R2584E.1.CEL2.078459.30%39.10%1.60%1.40.761Y
56R2731E.2BXD20R2731E.2.CEL1.82514759.00%39.50%1.50%1.40.82 
57R2702E.2BXD21R2702E.2.CEL1.811128.6559.40%39.10%1.40%1.260.82 
58R2541E2.1BXD21R2541E2.1.CEL2.6312556.00%42.40%1.50%1.290.781 
59R2553E.1BXD22R2553E.1.CEL1.9511159.90%38.50%1.50%1.280.761Y
60R2700E.2BXD22R2700E.2.CEL1.858102.9661.50%37.10%1.30%1.480.792 
61R2558E-2.1BXD23R2558E-2.1.CEL2.233125.0558.60%39.90%1.50%1.430.772 
62R1086E.2BXD23R1086E.2.CEL2.233125.0558.60%39.90%1.50%1.430.772 
63R2719E.2BXD24R2719E.2.CEL1.47140.3861.50%37.20%1.30%1.380.792 
64R2589E2.1BXD24R2589E2.1.CEL2.6111257.50%40.90%1.60%1.240.81 
65R2573E-2.1BXD25R2573E-2.1.CEL3.157257.90%40.70%1.40%1.770.971 
66R2683E.2BXD25R2683E.2.CEL1.777115.6458.30%40.30%1.40%2.010.792 
67R2703E.2BXD27R2703E.2.CEL1.263134.7862.60%36.10%1.40%1.440.782 
68R2729E.3BXD27R2729E.3.CEL18757.90%40.60%1.50%1.560.843Y
69R2562E.3BXD28R2562E.3.CEL1.6511659.90%38.40%1.70%1.370.793Y
70R2721E.2BXD28R2721E.2.CEL2.065157.3956.10%42.40%1.50%1.310.812 
71R2561E.3BXD29R2561E.3.CEL17753.30%45.40%1.40%3.3619.663 
72R1258E.2BXD31R1258E.2.CEL2.063117.0959.00%39.50%1.50%1.540.782 
73R2597E.1BXD31R2597E.1.CEL2.379460.30%38.30%1.50%1.340.771Y
74R2563E.1BXD32R2563E.1.CEL1.5510261.90%36.70%1.40%1.50.81 
75R1216E.2BXD32R1216E.2.CEL2.23111.9958.80%39.80%1.40%1.350.792 
76R2542E.1BXD33R2542E.1.CEL2.139756.50%41.80%1.60%1.910.931 
77R857E.2BXD33R857E.2.CEL1.737113.9861.90%36.70%1.30%1.60.772 
78R1451E.2BXD34R1451E.2.CEL1.843140.0559.00%39.50%1.50%1.420.812Y
79R2585E.1BXD34R2585E.1.CEL2.647558.30%40.00%1.70%1.250.771 
80R2698E.3BXD36R2698E.3.CEL18659.70%39.00%1.30%1.460.783 
81R2705E.3BXD36R2705E.3.CEL18660.20%38.40%1.40%1.460.773 
82R2710E.2BXD38R2710E.2.CEL2.112122.158.80%39.80%1.40%1.370.782 
83R2532E.1BXD38R2532E.1.CEL2.049459.80%38.70%1.50%1.370.81Y
84R2574E.1BXD39R2574E.1.CEL1.989161.20%37.30%1.50%1.390.781 
85R2695E.2BXD39R2695E.2.CEL1.638122.760.80%37.80%1.50%1.420.82 
86R2699E.2BXD40R2699E.2.CEL1.827105.2361.70%36.90%1.40%1.420.812 
87R2590E.1BXD40R2590E.1.CEL2.717759.10%39.30%1.50%1.40.771Y
88R2696E.2BXD42R2696E.2.CEL1.622118.9562.00%36.60%1.50%1.530.792 
89R2596E.1BXD42R2596E.1.CEL2.6310859.00%39.60%1.50%1.240.81 
90R994E.2BXD43R994E.2.CEL1.966113.1260.80%37.80%1.40%1.660.82 
91R2607E.1BXD43R2607E.1.CEL2.4311558.60%40.00%1.40%1.310.761Y
92R2594E.1BXD44R2594E.1.CEL1.7711759.80%38.80%1.40%1.350.851 
93R2610E.2BXD44R2610E.2.CEL1.814142.9159.00%39.50%1.50%1.350.82 
94R2732E.2BXD45R2732E.2.CEL2.154122.4556.50%42.10%1.40%1.80.832 
95R2592E.1BXD45R2592E.1.CEL1.8510660.10%38.60%1.30%1.430.851Y
96R967E.2BXD48R967E.2.CEL1.948130.9557.30%41.20%1.50%1.630.812 
97R2606E.1BXD48R2606E.1.CEL2.5610658.90%39.70%1.40%1.350.831Y
98R2933E.3BXD50R2933E.3.CEL17252.90%45.60%1.50%2.450.983 
99R2937E.3BXD50R2937E.3.CEL18956.90%41.60%1.40%1.810.823 
100R2603E.1BXD51R2603E.1.CEL2.4911557.70%40.80%1.50%1.240.791 
101R1042E.2BXD51R1042E.2.CEL2.352104.1258.70%39.90%1.40%1.530.822 
102R2980E.3BXD55R2980E.3.CEL18256.90%41.70%1.50%1.770.843 
103R2690E.2BXD55R2690E.2.CEL1.887164.0156.10%42.30%1.60%1.430.82 
104R4176EBXD56R4176E.CEL4.7543.0863.00%35.60%1.30%1.390.814Y
105R4175EBXD56R4175E.CEL638.4961.30%37.30%1.40%1.470.814Y
106R1006E.3BXD60R1006E.3.CEL19854.90%43.70%1.50%2.70.863 
107R2725E.2BXD60R2725E.2.CEL1.551148.0159.80%38.80%1.40%1.430.792 
108R1074E.3BXD60R1074E.3.CEL111855.50%43.10%1.40%1.960.813 
109R2534E2.1BXD61R2534E2.1.CEL2.4711857.90%40.60%1.50%1.420.791 
110R2684E.2BXD61R2684E.2.CEL2.01131.0357.00%41.50%1.50%1.340.782 
111R1107E.3BXD62R1107E.3.CEL18355.20%43.40%1.40%2.430.933 
112R2681E.2BXD62R2681E.2.CEL2.086148.2457.20%41.30%1.50%1.290.812 
113R965E.3BXD62R965E.3.CEL193.5553.30%45.20%1.50%3.110.943 
114R1425E.2BXD63R1425E.2.CEL1.713659.30%39.30%1.40%1.430.822 
115R2576E.3BXD63R2576E.3.CEL18461.30%37.40%1.40%1.480.763 
116R943E-2.2BXD64R943E-2.2.CEL1.591141.3460.10%38.40%1.50%1.320.762 
117R2611E.1BXD64R2611E.1.CEL2.299258.00%40.50%1.50%1.571.061 
118R2689E.2BXD65R2689E.2.CEL1.721142.4459.90%38.60%1.50%1.380.762 
119R2583E.1BXD65R2583E.1.CEL2.497056.90%41.50%1.60%1.671.011 
120R2728E.2BXD66R2728E.2.CEL1.714137.4559.40%39.00%1.60%1.380.792 
121R2536E2.1BXD66R2536E2.1.CEL2.7410956.10%42.30%1.70%1.280.791 
122R1207E.2BXD66R1207E.2.CEL1.681136.8660.40%38.10%1.50%1.450.772 
123R1192E.2BXD67R1192E.2.CEL2.126123.3757.90%40.60%1.50%1.50.82 
124R2727E.3BXD67R2727E.3.CEL182.5556.10%42.40%1.50%1.970.872 
125R2691E.3BXD67R2691E.3.CEL19054.80%43.80%1.50%2.610.813 
126R2551E.1BXD68R2551E.1.CEL2.499254.30%44.10%1.60%2.911.551 
127R2726E.2BXD68R2726E.2.CEL1.811153.0958.70%39.80%1.50%1.390.782 
128R2593E.1BXD69R2593E.1.CEL1.6712859.20%39.50%1.30%1.470.921Y
129R975E.2BXD70R975E.2.CEL1.841137.9758.00%40.50%1.40%1.360.792 
130R2537E2.1BXD70R2537E2.1.CEL2.939958.00%40.50%1.60%1.290.751 
131R4531EBXD71R4531E.CEL4.7743.4862.40%36.30%1.40%1.230.774Y
132R4532EBXD71R4532E.CEL5.8940.6860.90%37.60%1.50%1.240.794Y
133R2779E.2BXD73R2779E.2.CEL1.746121.1159.60%39.00%1.40%1.50.82 
134R3024E.3BXD73R3024E.3.CEL178.0551.70%46.60%1.70%2.30.943 
135R2565E.1BXD75R2565E.1.CEL1.7910258.00%40.50%1.50%2.313.471 
136R1397E-re.2BXD75R1397E-re.2.CEL1.449189.7159.60%39.00%1.40%1.390.822 
137R2687E.3BXD77R2687E.3.CEL18058.00%40.60%1.40%1.570.83Y
138R2717E.2BXD77R2717E.2.CEL1.79784.4361.60%36.90%1.40%1.490.762 
139R1421E.3BXD77R1421E.3.CEL19452.40%46.20%1.40%2.290.823 
140R2579E.1BXD80R2579E.1.CEL2.427259.20%39.40%1.50%1.730.821 
141R2686E.2BXD80R2686E.2.CEL2.342119.6356.00%42.60%1.50%1.380.792 
142R2956E.3BXD83R2956E.3.CEL18455.40%43.20%1.40%1.390.843 
143R2960E.3BXD83R2960E.3.CEL18056.60%41.90%1.50%1.50.823Y
144R2922E.3BXD84R2922E.3.CEL19157.80%40.80%1.50%1.470.833Y
145R2895E.3BXD84R2895E.3.CEL17558.30%40.20%1.50%1.560.773Y
146R2692E.2BXD85R2692E.2.CEL1.423160.8760.20%38.30%1.40%1.460.792 
147R2715E.2BXD85R2715E.2.CEL1.488142.661.20%37.30%1.40%1.50.782 
148R1405E.2BXD86R1405E.2.CEL2.351119.3456.40%42.20%1.40%1.640.812 
149R1225E.3BXD86R1225E.3.CEL17153.90%44.60%1.40%3.21.613 
150R2724E.2BXD87R2724E.2.CEL1.906113.7160.70%37.90%1.40%1.450.792 
151R2540E.1BXD87R2540E.1.CEL2.339361.10%37.40%1.40%1.220.811Y
152R1433E.2BXD89R1433E.2.CEL12.24157.70%40.80%1.50%1.410.782 
153R2546E.1BXD89R2546E.1.CEL1.999658.60%39.70%1.70%1.470.781 
154R2578E2.1BXD90R2578E2.1.CEL2.799258.60%39.80%1.60%1.520.771Y
155R859E.2BXD90R859E.2.CEL1.847152.2257.90%40.70%1.40%1.360.772 
156R2682E.2BXD92R2682E.2.CEL1.547156.3160.40%38.20%1.40%1.370.772 
157R1388E.3BXD92R1388E.3.CEL16360.00%38.60%1.40%1.851.033 
158R1322E.3BXD92R1322E.3.CEL18055.90%42.60%1.50%1.750.743 
159R2733E.2BXD96R2733E.2.CEL1.7113.9962.10%36.60%1.30%1.40.782 
160R2554E.1BXD96R2554E.1.CEL2.189360.20%38.30%1.50%1.460.771Y
161R2649E.2BXD97R2649E.2.CEL2.343119.0457.50%41.20%1.40%1.530.82 
162R2577E.1BXD97R2577E.1.CEL2.077759.50%39.10%1.40%1.871.291 
163R2645E.3BXD98R2645E.3.CEL18859.40%39.20%1.50%1.590.813Y
164R2688E.2BXD98R2688E.2.CEL1.772145.2458.50%40.00%1.50%1.480.812 
165R4533EBXD99R4533E.CEL137.6960.30%38.20%1.40%1.330.894Y
166R4534EBXD99R4534E.CEL5.6936.6262.90%35.70%1.40%1.160.84Y
167R2885E.3BXSB/MpJR2885E.3.CEL17658.10%40.60%1.30%1.881.063 
168R2883E.3BXSB/MpJR2883E.3.CEL17156.40%42.00%1.50%1.590.843Y
169R1700E.1C3H/HeJR1700E.1.CEL2.986960.80%37.90%1.40%1.480.781 
170R1704E.1C3H/HeJR1704E.1.CEL2.588860.10%38.60%1.30%1.380.841 
171R2605E.1C57BL/6JR2605E.1.CEL1.8213160.50%38.20%1.30%1.320.81Y
172R0871EC57BL/6JR0871E.CEL6.2437.3861.90%36.70%1.40%1.410.84Y
173R0872E.1C57BL/6JR0872E.1.CEL3.138958.90%39.60%1.50%1.30.791Y
174R0872EC57BL/6JR0872E.CEL3.12888.5858.90%39.60%1.50%1.30.791 
175R4507EC57BL/6J-NyxR4507E.CEL8.1337.559.30%39.30%1.40%1.320.84Y
176R4508EC57BL/6J-NyxR4508E.CEL6.3337.2660.90%37.80%1.30%1.240.824Y
177R4505EC57BL/6J-Rpe65R4505E.CEL5.9837.4861.80%36.80%1.40%1.450.854Y
178R4506EC57BL/6J-Rpe65R4506E.CEL6.9437.961.10%37.50%1.30%1.50.834Y
179R4535EC57BLKS/JR4535E.CEL6.5937.2861.20%37.30%1.40%1.260.834Y
180R4536EC57BLKS/JR4536E.CEL140.7160.30%38.20%1.50%1.250.774Y
181R2564E.1CAST/EiJR2564E.1.CEL1.948958.50%39.90%1.60%1.60.771 
182R2580E.1CAST/EiJR2580E.1.CEL2.099558.20%40.10%1.70%1.40.761 
183R4537ECBA/CaJR4537E.CEL138.4560.60%37.90%1.50%1.630.824Y
184R4538ECBA/CaJR4538E.CEL5.8939.1861.70%36.90%1.40%1.450.84Y
185R4539ECZECHII/EiJR4539E.CEL7.7337.158.30%40.10%1.50%1.70.954Y
186R4540ECZECHII/EiJR4540E.CEL11.0436.6953.00%45.30%1.70%1.831.324 
187R2600E.1D2B6F1R2600E.1.CEL2.479558.10%40.20%1.70%1.410.781Y
188R2604E.1D2B6F1R2604E.1.CEL2.669059.40%39.20%1.50%1.280.791Y
189R1002E.3DBA/2JR1002E.3.CEL110254.80%43.70%1.50%2.840.833 
190R4541EDBA/2JR4541E.CEL143.461.40%37.00%1.50%1.370.734Y
191R959E.3DBA/2JR959E.3.CEL189.9753.20%45.30%1.50%3.661.094 
192R2572E.1DBA/2JR2572E.1.CEL2.417955.50%42.90%1.60%1.370.791 
193R4542EDBA/2JR4542E.CEL5.739.9561.00%37.40%1.50%1.230.814Y
194R2771E.3FVB/NJR2771E.3.CEL17055.30%43.20%1.50%1.690.833 
195R2772E.3FVB/NJR2772E.3.CEL17655.20%43.40%1.40%2.131.023 
196R2636E.1KK/HlJR2636E.1.CEL2.619358.90%39.50%1.50%1.390.761Y
197R2637E.1KK/HlJR2637E.1.CEL2.1910359.40%39.00%1.50%1.30.791Y
198R0999E.1LG/JR0999E.1.CEL2.458259.40%39.10%1.50%1.380.791Y
199R1004E.1LG/JR1004E.1.CEL2.449258.70%39.80%1.50%1.380.791Y
200R4543ELP/JR4543E.CEL6.5741.9960.30%38.20%1.50%1.280.754Y
201R4544ELP/JR4544E.CEL4.5639.962.40%36.10%1.50%1.230.774Y
202R2858E.3MOLF/EiJR2858E.3.CEL16453.80%44.70%1.50%1.590.953 
203R2919.3MOLF/EiJR2919.3.CEL16452.40%46.00%1.60%2.151.073 
204R1688E.1NOD/LtJR1688E.1.CEL2.669858.60%39.90%1.50%1.260.81Y
205R2566E-2.1NOD/LtJR2566E-2.1.CEL3.036959.80%38.80%1.50%1.380.751Y
206R4545ENZB/BlNJR4545E.CEL4.2343.4862.10%36.40%1.50%1.330.764Y
207R4546ENZB/BlNJR4546E.CEL6.2744.2259.40%39.10%1.50%1.170.824Y
208R2535E.1NZO/HlLtJR2535E.1.CEL1.898660.40%38.20%1.40%1.410.851 
209R2550E.1NZO/HlLtJR2550E.1.CEL1.798760.70%37.80%1.50%1.520.821 
210R2817E.3NZW/LacJR2817E.3.CEL15950.90%47.60%1.50%3.591.483 
211R2810ENZW/LacJR2810E.CEL       3 
212R2810E.3NZW/LacJR2810E.3.CEL17457.00%41.70%1.40%2.151.034Y
213R4547EPANCEVO/EiJR4547E.CEL5.2751.3457.20%41.10%1.70%1.70.834 
214R4548EPANCEVO/EiJR4548E.CEL10.5437.3950.30%48.00%1.70%1.681.094 
215R2635E.1PWD/PhJR2635E.1.CEL3.728054.20%44.10%1.70%1.530.851 
216R2634E.1PWD/PhJR2634E.1.CEL3.299055.90%42.50%1.60%1.570.811 
217R2544E.1PWK/PhJR2544E.1.CEL2.210854.90%43.50%1.70%1.360.821 
218R2549E.1PWK/PhJR2549E.1.CEL2.288457.30%41.20%1.50%1.570.831 
219R4550ESJL/JR4550E.CEL5.3540.4462.30%36.20%1.40%1.240.794 
220R2368E.1WSB/EiJR2368E.1.CEL2.578659.50%39.10%1.40%1.290.741Y
221R2547E.1WSB/EiJR2547E.1.CEL2.149058.20%40.10%1.60%1.320.771Y
-
diff --git a/general/datasets/Eye_M2_0908_R_MT/summary.rtf b/general/datasets/Eye_M2_0908_R_MT/summary.rtf deleted file mode 100644 index 44b7e23..0000000 --- a/general/datasets/Eye_M2_0908_R_MT/summary.rtf +++ /dev/null @@ -1,12 +0,0 @@ -

FINAL RECOMMENDED EYE DATA SET. The HEIMED September 2008 RMA data release provides estimates of gene expression in whole eyes of 103 lines of young adult mice generated using 221 Affymetrix M430 2.0 arrays. This data set is intended for exploration of the genetics and genomics of the mouse eye, retina, lens, retinal pigment epithelium, cornea, iris and choroid. Data were generated at UTHSC with support from a grant from Dr. Barrett Haik, Director of the Hamilton Eye Institute (HEI). We used pooled RNA samples, usually two independent pools--one male, one female pool--for most lines of mice. This data set was processed using the RMA protocol. A total of 2223 probes sets are associated with LRS values greater than 46 (LOD >10).

- -

Users of these mouse eye data may also find the following complementary resources extremely useful:

- -
    -
  1. NEIBank collection of ESTs and SAGE data.
    2. -
  2. RetNet: the Retinal Information Network--tables of genes and loci causing inherited retinal diseases
    3. -
  3. Mouse Retina SAGE Library from the Cepko laboratory. This site provides extensive developmental data from as early as embryonic day E12.5.
    4. -
  4. Digital reference of ophthalmology from Columbia provides high quality photographs of human ocular diseases, case studies, and short explanations. This reference does not have a molecular focus.
    5. -
  5. Mouse Retinal Developmental Gene Expression data sets from the Friedlander laboratory. This site provides extensive developmental data using the Affymetrix U74 v 2 array (predecessor of the M430).
    6. -
  6. Data sets on differential gene expression in anatomical compartments of the human eye from Pat Brown's lab. View expression signatures for different ocular tissues using the geneXplorer 2.0.
    7. -
diff --git a/general/datasets/Eye_M2_0908_R_MT/tissue.rtf b/general/datasets/Eye_M2_0908_R_MT/tissue.rtf deleted file mode 100644 index 9b6ee0f..0000000 --- a/general/datasets/Eye_M2_0908_R_MT/tissue.rtf +++ /dev/null @@ -1,2058 +0,0 @@ -

Tissue preparation protocol. Animal were killed by rapid cervical dislocation. Eyes were removed immediately and placed in RNAlater at room temperature. Usually six eyes from animals with a common sex, age, and strain were stored in a single tube.

- -

Each array was hybridized with a pool of cRNA from 4 to 8 eyes from 2 to 4 animals. RNA was extracted at UTHSC by Zhiping Jia. If tissue was saved for RNA extraction at a later time, eyes were placed directly in RNAlater (Ambion, Inc.) and treated per the manufacturer’s directions. If eyes were used for immediate RNA extraction then we proceeded immediately to the next steps.

- -

Dissecting and preparing eyes for RNA extraction

- -
    -
  1. Place eyes for RNA extraction in RNA STAT-60 (Tel-Test Inc.) and process per manufacturer’s instructions (in brief form below).
    2. -
  2. Store RNA in 75% ethanol at –80 deg. C until use.
    3. -
- -

Total RNA was extracted with RNA STAT-60 (Tel-Test Inc.) according to the manufacturer's instructions. Briefly we:

- -
    -
  1. homogenize tissue samples in the RNA STAT-60 (1 ml/50 to 100 mg tissue)
    2. -
  2. allowed the homogenate to stand for 5 min at room temperature
    3. -
  3. added 0.2 ml of chloroform per 1 ml RNA STAT-60
    4. -
  4. shook the sample vigorously for 15 sec and let the sample sit at room temperature for 3 min
    5. -
  5. centrifuged at 12,000 G for 15 min
    6. -
  6. transfered the aqueous phase to a fresh tube
    7. -
  7. added 0.5 ml of isopropanol per 1 ml RNA STAT-60
    8. -
  8. vortexed and allowed sample to stand at room temperature for 5-10 min
    9. -
  9. centrifuged at 12,000 G for 10-15 min
    10. -
  10. removed the supernatant and washed the RNA pellet with 75% ethanol
    11. -
  11. stored the pellet in 75% ethanol at -80 deg C until use
    12. -
- -

Sample Processing. All samples were processed in the VA Medical Center, Memphis, Rheumatology Disease Research Core Center led by Dr. Weikuan Gu. All arrays were processed by Dr. Yan Jiao. In brief, samples were purified using a standard sodium acetate in alcohol method (recommended by Affymetrix). The RNA quality was checked using a 1% agarose gel. The 18S and 28S bands had to be clear and the 28S band had to be more prominent. RNA concentation was measured using a spectrophotometer. The 260/280 ratios had to be greater than 1.7, and the majority were 1.8 or higher. We used a total of 8 micrograms of RNA as starting amount for cDNA synthesis using a standard Eberwine T7 polymerase method (Superscript II RT, Invitrogen Inc., Affy Part No 900431, GeneChip Expression 3' Amplification One-Cyle cDNA Synthesis Kit). The Affymetrix IVT labeling kit (Affy 900449) was used to generate labeled cRNA. At this point the cRNA was evaluated again using both the 260/280 ratio (values of 2.0 or above were acceptable) and 1% agarose gel inspection of the product (a size range from 200 to 7000 bp is considered suitable for use). We used 45 micrograms of labeled cRNA for fragmentation. Those samples that passed both QC steps (<10% usually fail) were then sheared using a fragmentation buffer included in the Affymetrix GeneChip Sample Cleanup Module (Part No.900371). After fragmentation, samples were either stored at -80 deg. C until use (roughly one third) or were used immediately for hybridization.

- -

Dealing with ocular pigmentation: Variable ocular pigmentation is a potential confound in a study of the whole eye transcriptome. Even the most careful RNA preparations taken from brown and beige colored mice tend to have faint residual pigmentation that affects hybridization signal. To address this problem, Dr. Yan Jiao purified total RNA using the Qiagen RNeasy MinElute Cleanup Kit (Cat No. 74204) all four batches.

- -

Replication, sex, and sample balance: Our goal was to obtain data for independent biological sample pools from both sexes for most lines of mice. The four batches of arrays included in this final data set, collectively represent a reasonably well balanced sample of males and females, in general without within-strain-by-sex replication. Two strains are represented by a single male sample pool (BXD29 and A/J). Four lines are represented by two or three male sample pools (all of the five DeltaGen KO line). The SJL/J may be a single mixed sex sample. Users can study possible sex effects by comparing any results of expression data to that of a surrogate measurement that summarizes the overall sex balance of HEIMED. To do this just compare your data to those of probe sets 1427262_at (Xist, high in females) and probe set 1426438_at (Ddx3y, high in males). These two sex-specific probes are quantitative surrogates for the sex balance in this data set.

- -

Technical duplicates: One sample, highlighted in the tables below, is a technical duplicate. The pair of technical duplicates were both of high quality. For statistical analysis, they should be combined and treated as single biological sample.

- -

Batch structure: This data set consists of four batches (Table 2, far right column). The final September 2008 data set consists of a total of 221 arrays and 220 independent samples.

- -
    -
  1. Batch 1: November 2005, n = 78 arrays original arrays of which 76 were accepted into this final data set.
    2. -
  2. Batch 2: January 2006, n = 62 arrays of which 62 were accepted.
    3. -
  3. Batch 3: August 2006, n = 39 arrays of which 36 were accepted. (These three batches, including some arrays that were eventually dropped from the final 2008 data set, were combined to form the September 2006 data set.)
    4. -
  4. Batch 4: Summer 2008, n = 53 arrays of which 47 were accepted.
    5. -
- -

Table 1: HEIMED case IDs, including sample tube ID, strain, age, sex, and source of mice (see Table 2 for information on array quality control)

- -

 

- - - - - - - -
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
IndexTubeIDGroupStrainAgeSexSource
1R2595E.1GDP129S1/SvImJ59FUTHSC RW
2R2533E.1GDP129S1/SvImJ60MUTHSC RW
3R0754E.1GDPA/J60MJAX
4R4521EKOB6129P2F2N1-Clcn369MTChoi_Deltagen
5R4522EKOB6129P2F2N1-Clcn369MTChoi_Deltagen
6R4523EKOB6129P2F2N1-Clcn367MTChoi_Deltagen
7R4526EKOB6129P2F2N1-Gabbr116FTChoi_Deltagen
8R4509EKOB6129P2F2N1-Gabbr116MTChoi_Deltagen
9R4510EKOB6129P2F2N1-Gabbr119MTChoi_Deltagen
10R4511EKOB6129P2F2N1-Gabbr120MTChoi_Deltagen
11R4524EKOB6129P2F2N1-Gabbr119MTChoi_Deltagen
12R4525EKOB6129P2F2N1-Gabbr122MTChoi_Deltagen
13R4515EKOB6129P2F2N1-Gabra167MTChoi_Deltagen
14R4516EKOB6129P2F2N1-Gabra169MTChoi_Deltagen
15R4517EKOB6129P2F2N1-Gabra167MTChoi_Deltagen
16R4512EKOB6129P2F2N1-Gnb522FTChoi_Deltagen
17R4513EKOB6129P2F2N1-Gnb525MTChoi_Deltagen
18R4514EKOB6129P2F2N1-Gnb522MTChoi_Deltagen
19R4518EKOB6129P2F2N1-Gpr1970MTChoi_Deltagen
20R4519EKOB6129P2F2N1-Gpr1968MTChoi_Deltagen
21R2601E.1GDP BXDB6D2F173FUTHSC RW
22R2602E.1GDP BXDB6D2F173MUTHSC RW
23R1676E.1GDPBALB/cByJ83FJAX
24R1672E.1GDPBALB/cByJ83MJAX
25R4530EGDPBALB/cJ66FJAX
26R4529EGDPBALB/cJ66MJAX
27R2704E.2BXDBXD159FUTHSC RW
28R2707E.3BXDBXD159MBIDMC GR
29R1231E.2BXDBXD264FUTHSC RW
30R2598E.1BXDBXD261MUTHSC RW
31R2591E.1BXDBXD560FBIDMC GR
32R2714E.2BXDBXD558MUTHSC RW
33R2570E.1BXDBXD665FUTHSC RW
34R2694E.2BXDBXD658MUTHSC RW
35R2538E.1BXDBXD877FUTHSC RW
36R2709E.2BXDBXD861MUTHSC RW
37R2708E.2BXDBXD960FUTHSC RW
38R2569E.1BXDBXD967MUTHSC RW
39R2581E.1BXDBXD1165FUTHSC RW
40R2612E.2BXDBXD1170MUTHSC RW
41R2742E.2BXDBXD1271FUTHSC RW
42R2543E.1BXDBXD1263MUTHSC RW
43R2586E.1BXDBXD1360FBIDMC GR
44R877E.2BXDBXD1376MUTHSC RW
45R2557E.1BXDBXD1460FBIDMC GR
46R1128E.2BXDBXD1465MUTHSC RW
47R2701E.3BXDBXD1560FBIDMC GR
48R2716E.2BXDBXD1560MUTHSC RW
49R2711E.2BXDBXD1661FUTHSC RW
50R2567E.1BXDBXD1660MBIDMC GR
51R2720E.2BXDBXD1859FUTHSC RW
52R2559E.1BXDBXD1859MBIDMC GR
53R2560E.1BXDBXD1960FBIDMC GR
54R2713E.2BXDBXD1960MUTHSC RW
55R2584E.1BXDBXD2059FBIDMC GR
56R2731E.2BXDBXD2060MUTHSC RW
57R2702E.2BXDBXD2159FUTHSC RW
58R2541E2.1BXDBXD2161MUTHSC RW
59R2553E.1BXDBXD2258FBIDMC GR
60R2700E.2BXDBXD2259MUTHSC RW
61R2558E-2.1BXDBXD2360FBIDMC GR
62R1086E.2BXDBXD2355MUTHSC RW
63R2719E.2BXDBXD24123FUTHSC RW
64R2589E2.1BXDBXD2459MBIDMC GR
65R2573E-2.1BXDBXD2567FUAB
66R2683E.2BXDBXD2558MUTHSC RW
67R2703E.2BXDBXD2760FUTHSC RW
68R2729E.3BXDBXD2768MUTHSC RW
69R2562E.3BXDBXD2860FBIDMC GR
70R2721E.2BXDBXD2860MUTHSC RW
71R2561E.3BXDBXD2960MBIDMC GR
72R1258E.2BXDBXD3157FUTHSC RW
73R2597E.1BXDBXD3161MBIDMC GR
74R2563E.1BXDBXD3263FUTHSC RW
75R1216E.2BXDBXD3276MUTHSC RW
76R2542E.1BXDBXD3367FUTHSC RW
77R857E.2BXDBXD3377MUTHSC RW
78R1451E.2BXDBXD3461FUTHSC RW
79R2585E.1BXDBXD3460MBIDMC GR
80R2698E.3BXDBXD3658FBIDMC GR
81R2705E.3BXDBXD3657MBIDMC GR
82R2710E.2BXDBXD3855FUTHSC RW
83R2532E.1BXDBXD3862MUTHSC RW
84R2574E.1BXDBXD3970FUTHSC RW
85R2695E.2BXDBXD3959MUTHSC RW
86R2699E.2BXDBXD4059FUTHSC RW
87R2590E.1BXDBXD4060MBIDMC GR
88R2696E.2BXDBXD4258FUTHSC RW
89R2596E.1BXDBXD4259MBIDMC GR
90R994E.2BXDBXD4360FUTHSC RW
91R2607E.1BXDBXD4367MUTHSC RW
92R2594E.1BXDBXD4463FUTHSC RW
93R2610E.2BXDBXD4468MUTHSC RW
94R2732E.2BXDBXD4563FUTHSC RW
95R2592E.1BXDBXD4562MUTHSC RW
96R967E.2BXDBXD4864FUTHSC RW
97R2606E.1BXDBXD4878MUTHSC RW
98R2933E.3BXDBXD5061FUTHSC RW
99R2937E.3BXDBXD5061MUTHSC RW
100R2603E.1BXDBXD5166FUTHSC RW
101R1042E.2BXDBXD5162MUTHSC RW
102R2980E.3BXDBXD5576FUTHSC RW
103R2690E.2BXDBXD5565MUTHSC RW
104R4176EBXDBXD5667FUTHSC RW
105R4175EBXDBXD5653MUTHSC RW
106R1006E.3BXDBXD6060FUTHSC RW
107R2725E.2BXDBXD6061FUTHSC RW
108R1074E.3BXDBXD6059MUTHSC RW
109R2534E2.1BXDBXD6170FUTHSC RW
110R2684E.2BXDBXD6162MUTHSC RW
111R1107E.3BXDBXD6254FUTHSC RW
112R2681E.2BXDBXD6262MUTHSC RW
113R965E.3BXDBXD6254MUTHSC RW
114R1425E.2BXDBXD6361FUTHSC RW
115R2576E.3BXDBXD6370MUTHSC RW
116R943E-2.2BXDBXD6456FUTHSC RW
117R2611E.1BXDBXD6468MUTHSC RW
118R2689E.2BXDBXD6563FUTHSC RW
119R2583E.1BXDBXD6560MUTHSC RW
120R2728E.2BXDBXD6667FUTHSC RW
121R2536E2.1BXDBXD6664FUTHSC RW
122R1207E.2BXDBXD6683MUTHSC RW
123R1192E.2BXDBXD6764FUTHSC RW
124R2727E.3BXDBXD6765FUTHSC RW
125R2691E.3BXDBXD6765MUTHSC RW
126R2551E.1BXDBXD6867FUTHSC RW
127R2726E.2BXDBXD6864MUTHSC RW
128R2593E.1BXDBXD6959FUTHSC RW
129R975E.2BXDBXD7064FUTHSC RW
130R2537E2.1BXDBXD7059MUTHSC RW
131R4531EBXDBXD7187FUTHSC RW
132R4532EBXDBXD7186MUTHSC RW
133R2779E.2BXDBXD7364FUTHSC RW
134R3024E.3BXDBXD7354MUTHSC RW
135R2565E.1BXDBXD7561FUTHSC RW
136R1397E-re.2BXDBXD7558MUTHSC RW
137R2687E.3BXDBXD7760FUTHSC RW
138R2717E.2BXDBXD77107MUTHSC RW
139R1421E.3BXDBXD7762MUTHSC RW
140R2579E.1BXDBXD8065FUTHSC RW
141R2686E.2BXDBXD8061MUTHSC RW
142R2956E.3BXDBXD8358FUTHSC RW
143R2960E.3BXDBXD8358MUTHSC RW
144R2922E.3BXDBXD8461FUTHSC RW
145R2895E.3BXDBXD8467MUTHSC RW
146R2692E.2BXDBXD8563FUTHSC RW
147R2715E.2BXDBXD8591MUTHSC RW
148R1405E.2BXDBXD8658FUTHSC RW
149R1225E.3BXDBXD8658MUTHSC RW
150R2724E.2BXDBXD8763FUTHSC RW
151R2540E.1BXDBXD8763MUTHSC RW
152R1433E.2BXDBXD8963FUTHSC RW
153R2546E.1BXDBXD8966MUTHSC RW
154R2578E2.1BXDBXD9061FUTHSC RW
155R859E.2BXDBXD9072MUTHSC RW
156R2682E.2BXDBXD9266FUTHSC RW
157R1388E.3BXDBXD9262FUTHSC RW
158R1322E.3BXDBXD9255MUTHSC RW
159R2733E.2BXDBXD9667FUTHSC RW
160R2554E.1BXDBXD9667MUTHSC RW
161R2649E.2BXDBXD9774FUTHSC RW
162R2577E.1BXDBXD9755MUTHSC RW
163R2645E.3BXDBXD9866FUTHSC RW
164R2688E.2BXDBXD9867MUTHSC RW
165R4533EBXDBXD9980FUTHSC RW
166R4534EBXDBXD9991MUTHSC RW
167R2885E.3GDPBXSB/MpJ61FBIDMC GR
168R2883E.3GDPBXSB/MpJ61MBIDMC GR
169R1700E.1GDPC3H/HeJ83FUTHSC RW
170R1704E.1GDPC3H/HeJ83MUTHSC RW
171R2605E.1GDP BXDC57BL/6J79FUTHSC RW
172R0871EGDP BXDC57BL/6J65FUTHSC RW
173R0872E.1GDP BXDC57BL/6J66MUTHSC RW
174R0872EGDP BXDC57BL/6J66MUTHSC RW
175R4507EKOC57BL/6J-Nyx57MGeisert
176R4508EKOC57BL/6J-Nyx57MGeisert
177R4505EKOC57BL/6J-Rpe6557FGeisert
178R4506EKOC57BL/6J-Rpe6557FGeisert
179R4535EGDPC57BLKS/J66FJAX
180R4536EGDPC57BLKS/J66MJAX
181R2564E.1GDPCAST/EiJ64FJAX
182R2580E.1GDPCAST/EiJ64MJAX
183R4537EGDPCBA/CaJ66FJAX
184R4538EGDPCBA/CaJ66MJAX
185R4539EGDPCZECHII/EiJ66FJAX
186R4540EGDPCZECHII/EiJ66MJAX
187R2600E.1GDP BXDD2B6F172FUTHSC RW
188R2604E.1GDP BXDD2B6F169MUTHSC RW
189R1002E.3GDP BXDDBA/2J72FUTHSC RW
190R4541EGDP BXDDBA/2J65FJAX
191R959E.3GDP BXDDBA/2J60MUTHSC RW
192R2572E.1GDP BXDDBA/2J65MUTHSC RW
193R4542EGDP BXDDBA/2J59MJAX
194R2771E.3GDPFVB/NJ60FBIDMC GR
195R2772E.3GDPFVB/NJ60MBIDMC GR
196R2636E.1GDPKK/HlJ64FUTHSC RW
197R2637E.1GDPKK/HlJ64MUTHSC RW
198R0999E.1GDPLG/J57FUTHSC RW
199R1004E.1GDPLG/J65MUTHSC RW
200R4543EGDPLP/J65FJAX
201R4544EGDPLP/J65MJAX
202R2858E.3GDPMOLF/EiJ60FBIDMC GR
203R2919.3GDPMOLF/EiJ60MBIDMC GR
204R1688E.1GDPNOD/LtJ66FJAX
205R2566E-2.1GDPNOD/LtJ76MUTHSC RW
206R4545EGDPNZB/BlNJ61FBIDMC GR
207R4546EGDPNZB/BlNJ58MBIDMC GR
208R2535E.1GDPNZO/HlLtJ62FJAX
209R2550E.1GDPNZO/HlLtJ96MJAX
210R2817E.3GDPNZW/LacJ65FBIDMC GR
211R2810EGDPNZW/LacJ60MBIDMC GR
212R2810E.3GDPNZW/LacJ60MBIDMC GR
213R4547EGDPPANCEVO/EiJ68FJAX
214R4548EGDPPANCEVO/EiJ68MJAX
215R2635E.1GDPPWD/PhJ62FJAX
216R2634E.1GDPPWD/PhJ62MJAX
217R2544E.1GDPPWK/PhJ63FJAX
218R2549E.1GDPPWK/PhJ83MJAX
219R4550EGDPSJL/J65M+FJAX
220R2368E.1GDPWSB/EiJ67FUTHSC RW
221R2547E.1GDPWSB/EiJ67MUTHSC RW
-
-- cgit v1.2.3